The purpose of this study was the assessment of the frequency and sequence of NPM1 mutations among Iranian AML patients, the detection of the frequency of FLT3/ITD mutations in this group and to examine the relationship between these mutations and the FAB (French-American-British classification) subtypes of AML. This evidence concerns the gene NPM1 and acute myeloid leukemia.